Skip to content

VBI Vaccines Inc/BC

CIK 0000764195

← back to feed
Revenue (TTM)
$9.04M
+702.4% YoY Q1 May 2024
Net Income (TTM)
−$110.72M
+18.1% YoY Q1 May 2024
EPS Diluted (TTM)
−$10.14
+54.2% YoY Q1 May 2024
Gross Margin
3.5%
Q1 May 2024
Operating Margin
-865.9%
Q1 May 2024
Net Margin
-1,224.4%
Q1 May 2024
Free Cash Flow (TTM)
−$61.75M
Q1 May 2024
Cash
$101.34M
Q1 May 2024
Total Debt
$96.58M
Q1 May 2024
Shares Outstanding
28.68M sh
Q1 May 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings